CLINICAL_TRIALS
research
· 2026-03-20
Clinical Trial Update: Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs) [NA]
Summary
This clinical trial is testing focused ultrasound neuromodulation with Exablate for opioid use disorder and other substance use disorders and is currently recru…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: InSightec | Conditions: Opioid-use Disorder, Substance Use Disorders | NA | Status: RECRUITING